University researchers to tackle drug-resistant disease that jumps from pigs to humans
Dr Michael Jarvis's The Vaccine Group and Professor Mat Upton have received £700,000 funding from the Department of Health and Social Care (DHSC) to tackle a disease which can cause meningitis, blood poisoning, or septicaemia.
Research to identify and target high blood pressure indicators
High blood pressure, or hypertension, is a leading cause of stroke and heart attacks worldwide – and one in four people have it. New research led by the University of Plymouth could identify how to target this condition and other blood vessel problems.
Research grant to develop vaccine for mastitis in cows
University spinout company The Vaccine Group (TVG), led by Dr Michael Jarvis, has received £50,000 from the global Bacterial Vaccine Network (“BactiVac”) and will use the grant to run a proof-of-concept study
University spin-out company to develop new antibiotics
New University of Plymouth spinout company Amprologix has been established to help tackle the problem of antibiotic resistance – by developing new antibiotics and bringing them to market. It is led by Professor Mat Upton in collaboration with Frontier IP
School of Biomedical Sciences – Teaching and Learning
Find out about the University of Plymouth's School of Biomedical Sciences teaching and learning.
Placements with the School of Biomedical Sciences
University of Plymouth's Careers and Employability Service: Placements with the School of Biomedical Sciences